{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T21:49:30Z","timestamp":1794692970981,"version":"4.9.1"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T00:00:00Z","timestamp":1736553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T00:00:00Z","timestamp":1736553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32271202, 31971076"],"award-info":[{"award-number":["32271202, 31971076"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-55939-2","type":"journal-article","created":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T12:21:53Z","timestamp":1736598113000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Inhibited peroxidase activity of peroxiredoxin 1 by palmitic acid exacerbates nonalcoholic steatohepatitis in male mice"],"prefix":"10.1038","volume":"16","author":[{"given":"Wen","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghao","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7759-9551","authenticated-orcid":false,"given":"Yue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangzhao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6166-2089","authenticated-orcid":false,"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danting","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihui","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0656-6315","authenticated-orcid":false,"given":"Hualiang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaixian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyan","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7049-1560","authenticated-orcid":false,"given":"Huiyong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4727-2380","authenticated-orcid":false,"given":"Weiping J.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3864-8382","authenticated-orcid":false,"given":"Cheng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4317-7327","authenticated-orcid":false,"given":"Xiangyang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,11]]},"reference":[{"key":"55939_CR1","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/hep.26672","volume":"59","author":"AL Birkenfeld","year":"2014","unstructured":"Birkenfeld, A. L. & Shulman, G. I. Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes. Hepatology 59, 713\u2013723 (2014).","journal-title":"Hepatology"},{"key":"55939_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi, Z. M. et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64, 73\u201384 (2016).","journal-title":"Hepatology"},{"key":"55939_CR3","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","volume":"184","author":"R Loomba","year":"2021","unstructured":"Loomba, R., Friedman, S. L. & Shulman, G. I. Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell 184, 2537\u20132564 (2021).","journal-title":"Cell"},{"key":"55939_CR4","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/s41574-021-00507-z","volume":"17","author":"D Ferguson","year":"2021","unstructured":"Ferguson, D. & Finck, B. N. Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus. Nat. Rev. Endocrinol. 17, 484\u2013495 (2021).","journal-title":"Nat. Rev. Endocrinol."},{"key":"55939_CR5","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41575-021-00448-y","volume":"18","author":"G Targher","year":"2021","unstructured":"Targher, G., Corey, K. E., Byrne, C. D. & Roden, M. The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments. Nat. Rev. Gastroenterol. Hepatol. 18, 599\u2013612 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"55939_CR6","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrgastro.2010.41","volume":"7","author":"JS Lim","year":"2010","unstructured":"Lim, J. S., Mietus-Snyder, M., Valente, A., Schwarz, J. M. & Lustig, R. H. The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. Nat. Rev. Gastroenterol. Hepatol. 7, 251\u2013264 (2010).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"55939_CR7","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M. & Sanyal, A. J. Mechanisms of NAFLD development and therapeutic strategies. Nat. Med 24, 908\u2013922 (2018).","journal-title":"Nat. Med"},{"key":"55939_CR8","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nrd.2015.3","volume":"15","author":"G Musso","year":"2016","unstructured":"Musso, G., Cassader, M. & Gambino, R. Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies. Nat. Rev. Drug Discov. 15, 249\u2013274 (2016).","journal-title":"Nat. Rev. Drug Discov."},{"key":"55939_CR9","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2020.02.025","volume":"152","author":"Z Chen","year":"2020","unstructured":"Chen, Z., Tian, R., She, Z., Cai, J. & Li, H. Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease. Free Radic. Biol. Med 152, 116\u2013141 (2020).","journal-title":"Free Radic. Biol. Med"},{"key":"55939_CR10","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1093\/emboj\/cdg009","volume":"22","author":"P Storz","year":"2003","unstructured":"Storz, P. & Toker, A. Protein kinase D mediates a stress-induced NF-kappaB activation and survival pathway. EMBO J. 22, 109\u2013120 (2003).","journal-title":"EMBO J."},{"key":"55939_CR11","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.jhep.2005.03.004","volume":"42","author":"D Pessayre","year":"2005","unstructured":"Pessayre, D. & Fromenty, B. NASH: a mitochondrial disease. J. Hepatol. 42, 928\u2013940 (2005).","journal-title":"J. Hepatol."},{"key":"55939_CR12","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.jhep.2017.06.001","volume":"67","author":"CR Gandhi","year":"2017","unstructured":"Gandhi, C. R. Hepatic stellate cell activation and pro-fibrogenic signals. J. Hepatol. 67, 1104\u20131105 (2017).","journal-title":"J. Hepatol."},{"key":"55939_CR13","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1146\/annurev-biochem-061516-045037","volume":"86","author":"H Sies","year":"2017","unstructured":"Sies, H., Berndt, C. & Jones, D. P. Oxidative Stress. Annu Rev. Biochem 86, 715\u2013748 (2017).","journal-title":"Annu Rev. Biochem"},{"key":"55939_CR14","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nchembio.1695","volume":"11","author":"MC Sobotta","year":"2015","unstructured":"Sobotta, M. C. et al. Peroxiredoxin-2 and STAT3 form a redox relay for H2O2 signaling. Nat. Chem. Biol. 11, 64\u201370 (2015).","journal-title":"Nat. Chem. Biol."},{"key":"55939_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/WOX.0b013e3182439613","volume":"5","author":"E Birben","year":"2012","unstructured":"Birben, E., Sahiner, U. M., Sackesen, C., Erzurum, S. & Kalayci, O. Oxidative stress and antioxidant defense. World Allergy Organ J. 5, 9\u201319 (2012).","journal-title":"World Allergy Organ J."},{"key":"55939_CR16","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1042\/CS20030285","volume":"106","author":"LA Videla","year":"2004","unstructured":"Videla, L. A. et al. Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients. Clin. Sci. (Lond.) 106, 261\u2013268 (2004).","journal-title":"Clin. Sci. (Lond.)"},{"key":"55939_CR17","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1146\/annurev-biochem-060815-014431","volume":"86","author":"SG Rhee","year":"2017","unstructured":"Rhee, S. G. & Kil, I. S. Multiple functions and regulation of mammalian peroxiredoxins. Annu Rev. Biochem 86, 749\u2013775 (2017).","journal-title":"Annu Rev. Biochem"},{"key":"55939_CR18","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.tibs.2015.05.001","volume":"40","author":"A Perkins","year":"2015","unstructured":"Perkins, A., Nelson, K. J., Parsonage, D., Poole, L. B. & Karplus, P. A. Peroxiredoxins: guardians against oxidative stress and modulators of peroxide signaling. Trends Biochem Sci. 40, 435\u2013445 (2015).","journal-title":"Trends Biochem Sci."},{"key":"55939_CR19","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/nchembio.85","volume":"4","author":"CC Winterbourn","year":"2008","unstructured":"Winterbourn, C. C. Reconciling the chemistry and biology of reactive oxygen species. Nat. Chem. Biol. 4, 278\u2013286 (2008).","journal-title":"Nat. Chem. Biol."},{"key":"55939_CR20","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1042\/BJ20091541","volume":"425","author":"AG Cox","year":"2009","unstructured":"Cox, A. G., Winterbourn, C. C. & Hampton, M. B. Mitochondrial peroxiredoxin involvement in antioxidant defence and redox signalling. Biochem J. 425, 313\u2013325 (2009).","journal-title":"Biochem J."},{"key":"55939_CR21","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1038\/emboj.2009.101","volume":"28","author":"J Cao","year":"2009","unstructured":"Cao, J. et al. Prdx1 inhibits tumorigenesis via regulating PTEN\/AKT activity. EMBO J. 28, 1505\u20131517 (2009).","journal-title":"EMBO J."},{"key":"55939_CR22","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1161\/CIRCRESAHA.108.174870","volume":"103","author":"J Kisucka","year":"2008","unstructured":"Kisucka, J. et al. Peroxiredoxin1 prevents excessive endothelial activation and early atherosclerosis. Circ. Res 103, 598\u2013605 (2008).","journal-title":"Circ. Res"},{"key":"55939_CR23","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.freeradbiomed.2019.04.012","volume":"137","author":"Y He","year":"2019","unstructured":"He, Y. et al. Circulating Peroxiredoxin-1 is a novel damage-associated molecular pattern and aggravates acute liver injury via promoting inflammation. Free Radic. Biol. Med 137, 24\u201336 (2019).","journal-title":"Free Radic. Biol. Med"},{"key":"55939_CR24","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/nm.2749","volume":"18","author":"T Shichita","year":"2012","unstructured":"Shichita, T. et al. Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain. Nat. Med 18, 911\u2013917 (2012).","journal-title":"Nat. Med"},{"key":"55939_CR25","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1002\/hep.32078","volume":"74","author":"Z Zhang","year":"2021","unstructured":"Zhang, Z. et al. Guanine nucleotide-binding protein g(i) subunit alpha 2 exacerbates nash progression by regulating peroxiredoxin 1-related inflammation and lipophagy. Hepatology 74, 3110\u20133126 (2021).","journal-title":"Hepatology"},{"key":"55939_CR26","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1080\/15548627.2018.1474995","volume":"14","author":"Y Min","year":"2018","unstructured":"Min, Y., Kim, M. J., Lee, S., Chun, E. & Lee, K. Y. Inhibition of TRAF6 ubiquitin-ligase activity by PRDX1 leads to inhibition of NFKB activation and autophagy activation. Autophagy 14, 1347\u20131358 (2018).","journal-title":"Autophagy"},{"key":"55939_CR27","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1002\/hep.24104","volume":"53","author":"SH Bae","year":"2011","unstructured":"Bae, S. H. et al. Concerted action of sulfiredoxin and peroxiredoxin I protects against alcohol-induced oxidative injury in mouse liver. Hepatology 53, 945\u2013953 (2011).","journal-title":"Hepatology"},{"key":"55939_CR28","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.ab.2004.12.008","volume":"338","author":"JA Kim","year":"2005","unstructured":"Kim, J. A., Park, S., Kim, K., Rhee, S. G. & Kang, S. W. Activity assay of mammalian 2-cys peroxiredoxins using yeast thioredoxin reductase system. Anal. Biochem 338, 216\u2013223 (2005).","journal-title":"Anal. Biochem"},{"key":"55939_CR29","unstructured":"Nelson K. J., Parsonage D. Measurement of peroxiredoxin activity. Curr. Protoc. Toxicol. Chapter 7, Unit7 10 (2011)."},{"key":"55939_CR30","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.jhep.2005.12.016","volume":"44","author":"E Bjornsson","year":"2006","unstructured":"Bjornsson, E., Nordlinder, H. & Olsson, R. Clinical characteristics and prognostic markers in disulfiram-induced liver injury. J. Hepatol. 44, 791\u2013797 (2006).","journal-title":"J. Hepatol."},{"key":"55939_CR31","doi-asserted-by":"publisher","first-page":"11989","DOI":"10.1039\/D0SC04888G","volume":"11","author":"S Ye","year":"2020","unstructured":"Ye, S., Hu, J. J., Zhao, Q. A. & Yang, D. Fluorescent probes for in vitro and in vivo quantification of hydrogen peroxide. Chem. Sci. 11, 11989\u201311997 (2020).","journal-title":"Chem. Sci."},{"key":"55939_CR32","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1126\/science.1080273","volume":"300","author":"HA Woo","year":"2003","unstructured":"Woo, H. A. et al. Reversing the inactivation of peroxiredoxins caused by cysteine sulfinic acid formation. Science 300, 653\u2013656 (2003).","journal-title":"Science"},{"key":"55939_CR33","doi-asserted-by":"publisher","first-page":"47361","DOI":"10.1074\/jbc.C300428200","volume":"278","author":"HA Woo","year":"2003","unstructured":"Woo, H. A. et al. Reversible oxidation of the active site cysteine of peroxiredoxins to cysteine sulfinic acid. Immunoblot detection with antibodies specific for the hyperoxidized cysteine-containing sequence. J. Biol. Chem. 278, 47361\u201347364 (2003).","journal-title":"J. Biol. Chem."},{"key":"55939_CR34","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cmet.2015.12.015","volume":"23","author":"J Font-Burgada","year":"2016","unstructured":"Font-Burgada, J., Sun, B. & Karin, M. Obesity and cancer: the oil that feeds the flame. Cell Metab. 23, 48\u201362 (2016).","journal-title":"Cell Metab."},{"key":"55939_CR35","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jhep.2017.11.014","volume":"68","author":"F Marra","year":"2018","unstructured":"Marra, F. & Svegliati-Baroni, G. Lipotoxicity and the gut-liver axis in NASH pathogenesis. J. Hepatol. 68, 280\u2013295 (2018).","journal-title":"J. Hepatol."},{"key":"55939_CR36","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.1233606","volume":"341","author":"D Martinez Molina","year":"2013","unstructured":"Martinez Molina, D. et al. Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay. Science 341, 84\u201387 (2013).","journal-title":"Science"},{"key":"55939_CR37","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1016\/j.cmet.2022.10.007","volume":"34","author":"D Cheng","year":"2022","unstructured":"Cheng, D. et al. MGAT2 inhibitor decreases liver fibrosis and inflammation in murine NASH models and reduces body weight in human adults with obesity. Cell Metab. 34, 1732\u20131748.e1735 (2022).","journal-title":"Cell Metab."},{"key":"55939_CR38","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1172\/JCI36714","volume":"119","author":"SC Benoit","year":"2009","unstructured":"Benoit, S. C. et al. Palmitic acid mediates hypothalamic insulin resistance by altering PKC-theta subcellular localization in rodents. J. Clin. Invest 119, 2577\u20132589 (2009).","journal-title":"J. Clin. Invest"},{"key":"55939_CR39","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1074\/jbc.274.1.305","volume":"274","author":"C Postic","year":"1999","unstructured":"Postic, C. et al. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. J. Biol. Chem. 274, 305\u2013315 (1999).","journal-title":"J. Biol. Chem."},{"key":"55939_CR40","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ceb.2005.02.001","volume":"17","author":"A Bourdeau","year":"2005","unstructured":"Bourdeau, A., Dube, N. & Tremblay, M. L. Cytoplasmic protein tyrosine phosphatases, regulation and function: the roles of PTP1B and TC-PTP. Curr. Opin. Cell Biol. 17, 203\u2013209 (2005).","journal-title":"Curr. Opin. Cell Biol."},{"key":"55939_CR41","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cmet.2014.05.011","volume":"20","author":"EN Gurzov","year":"2014","unstructured":"Gurzov, E. N. et al. Hepatic oxidative stress promotes insulin-STAT-5 signaling and obesity by inactivating protein tyrosine phosphatase N2. Cell Metab. 20, 85\u2013102 (2014).","journal-title":"Cell Metab."},{"key":"55939_CR42","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.cell.2018.09.053","volume":"175","author":"M Grohmann","year":"2018","unstructured":"Grohmann, M. et al. Obesity drives STAT-1-dependent NASH and STAT-3-dependent HCC. Cell 175, 1289\u20131306.e1220 (2018).","journal-title":"Cell"},{"key":"55939_CR43","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.semcdb.2008.06.004","volume":"19","author":"G Regis","year":"2008","unstructured":"Regis, G., Pensa, S., Boselli, D., Novelli, F. & Poli, V. Ups and downs: the STAT1:STAT3 seesaw of Interferon and gp130 receptor signalling. Semin Cell Dev. Biol. 19, 351\u2013359 (2008).","journal-title":"Semin Cell Dev. Biol."},{"key":"55939_CR44","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1080\/10715762.2018.1468564","volume":"52","author":"G Aldini","year":"2018","unstructured":"Aldini, G. et al. N-Acetylcysteine as an antioxidant and disulphide breaking agent: the reasons why. Free Radic. Res 52, 751\u2013762 (2018).","journal-title":"Free Radic. Res"},{"key":"55939_CR45","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.cmet.2019.10.014","volume":"31","author":"X Sun","year":"2020","unstructured":"Sun, X. et al. Neutralization of oxidized phospholipids ameliorates non-alcoholic steatohepatitis. Cell Metab. 31, 189\u2013206.e188 (2020).","journal-title":"Cell Metab."},{"key":"55939_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.101122","volume":"50","author":"K Pafili","year":"2021","unstructured":"Pafili, K. & Roden, M. Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans. Mol. Metab. 50, 101122 (2021).","journal-title":"Mol. Metab."},{"key":"55939_CR47","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.cmet.2015.04.004","volume":"21","author":"C Koliaki","year":"2015","unstructured":"Koliaki, C. et al. Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis. Cell Metab. 21, 739\u2013746 (2015).","journal-title":"Cell Metab."},{"key":"55939_CR48","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/hep.27420","volume":"61","author":"L Wang","year":"2015","unstructured":"Wang, L. et al. ALCAT1 controls mitochondrial etiology of fatty liver diseases, linking defective mitophagy to steatosis. Hepatology 61, 486\u2013496 (2015).","journal-title":"Hepatology"},{"key":"55939_CR49","doi-asserted-by":"publisher","first-page":"10829","DOI":"10.1021\/acs.chemrev.9b00371","volume":"119","author":"A Zeida","year":"2019","unstructured":"Zeida, A. et al. Catalysis of peroxide reduction by fast reacting protein thiols. Chem. Rev. 119, 10829\u201310855 (2019).","journal-title":"Chem. Rev."},{"key":"55939_CR50","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0031-9422(02)00513-7","volume":"62","author":"M Petersen","year":"2003","unstructured":"Petersen, M. & Simmonds, M. S. Rosmarinic acid. Phytochemistry 62, 121\u2013125 (2003).","journal-title":"Phytochemistry"},{"key":"55939_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108600","volume":"112","author":"TO Elufioye","year":"2019","unstructured":"Elufioye, T. O. & Habtemariam, S. Hepatoprotective effects of rosmarinic acid: Insight into its mechanisms of action. Biomed. Pharmacother. 112, 108600 (2019).","journal-title":"Biomed. Pharmacother."},{"key":"55939_CR52","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.3390\/nu12041166","volume":"12","author":"M Kim","year":"2020","unstructured":"Kim, M. et al. Lemon balm and its constituent, rosmarinic acid, alleviate liver damage in an animal model of nonalcoholic steatohepatitis. Nutrients 12, 1166 (2020).","journal-title":"Nutrients"},{"key":"55939_CR53","doi-asserted-by":"publisher","first-page":"98","DOI":"10.2119\/molmed.2015.00033","volume":"21","author":"L Mullen","year":"2015","unstructured":"Mullen, L., Hanschmann, E. M., Lillig, C. H., Herzenberg, L. A. & Ghezzi, P. Cysteine oxidation targets peroxiredoxins 1 and 2 for exosomal release through a novel mechanism of redox-dependent secretion. Mol. Med 21, 98\u2013108 (2015).","journal-title":"Mol. Med"},{"key":"55939_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2023.101789","volume":"76","author":"Z Bai","year":"2023","unstructured":"Bai, Z. et al. PRDX1 Cys52Ser variant alleviates nonalcoholic steatohepatitis by reducing inflammation in mice. Mol. Metab. 76, 101789 (2023).","journal-title":"Mol. Metab."},{"key":"55939_CR55","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1146\/annurev-biochem-013118-111829","volume":"88","author":"S Ma","year":"2019","unstructured":"Ma, S., Meng, Z., Chen, R. & Guan, K. L. The hippo pathway: biology and pathophysiology. Annu Rev. Biochem 88, 577\u2013604 (2019).","journal-title":"Annu Rev. Biochem"},{"key":"55939_CR56","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1002\/hep.30928","volume":"71","author":"M Mooring","year":"2020","unstructured":"Mooring, M. et al. Hepatocyte stress increases expression of yes-associated protein and transcriptional coactivator with pdz-binding motif in hepatocytes to promote parenchymal inflammation and fibrosis. Hepatology 71, 1813\u20131830 (2020).","journal-title":"Hepatology"},{"key":"55939_CR57","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/hep.30990","volume":"72","author":"K Song","year":"2020","unstructured":"Song, K. et al. Yes-associated protein in kupffer cells enhances the production of proinflammatory cytokines and promotes the development of nonalcoholic steatohepatitis. Hepatology 72, 72\u201387 (2020).","journal-title":"Hepatology"},{"key":"55939_CR58","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.cmet.2016.09.016","volume":"24","author":"X Wang","year":"2016","unstructured":"Wang, X. et al. Hepatocyte TAZ\/WWTR1 promotes inflammation and fibrosis in nonalcoholic steatohepatitis. Cell Metab. 24, 848\u2013862 (2016).","journal-title":"Cell Metab."},{"key":"55939_CR59","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.cmet.2020.03.010","volume":"31","author":"X Wang","year":"2020","unstructured":"Wang, X. et al. Cholesterol stabilizes TAZ in hepatocytes to promote experimental non-alcoholic steatohepatitis. Cell Metab. 31, 969\u2013986.e967 (2020).","journal-title":"Cell Metab."},{"key":"55939_CR60","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1002\/hep4.1405","volume":"3","author":"X Wang","year":"2019","unstructured":"Wang, X. et al. A therapeutic silencing rna targeting hepatocyte taz prevents and reverses fibrosis in nonalcoholic steatohepatitis in mice. Hepatol. Commun. 3, 1221\u20131234 (2019).","journal-title":"Hepatol. Commun."},{"key":"55939_CR61","doi-asserted-by":"publisher","first-page":"5558","DOI":"10.1074\/jbc.M110.194019","volume":"286","author":"CY Liu","year":"2011","unstructured":"Liu, C. Y. et al. PP1 cooperates with ASPP2 to dephosphorylate and activate TAZ. J. Biol. Chem. 286, 5558\u20135566 (2011).","journal-title":"J. Biol. Chem."},{"key":"55939_CR62","doi-asserted-by":"publisher","first-page":"6408","DOI":"10.1073\/pnas.91.14.6408","volume":"91","author":"M Dohadwala","year":"1994","unstructured":"Dohadwala, M. et al. Phosphorylation and inactivation of protein phosphatase 1 by cyclin-dependent kinases. Proc. Natl Acad. Sci. USA 91, 6408\u20136412 (1994).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"55939_CR63","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1073\/pnas.94.6.2168","volume":"94","author":"YG Kwon","year":"1997","unstructured":"Kwon, Y. G., Lee, S. Y., Choi, Y., Greengard, P. & Nairn, A. C. Cell cycle-dependent phosphorylation of mammalian protein phosphatase 1 by cdc2 kinase. Proc. Natl Acad. Sci. USA 94, 2168\u20132173 (1997).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"55939_CR64","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1002\/hep.22183","volume":"47","author":"Z Li","year":"2008","unstructured":"Li, Z., Berk, M., McIntyre, T. M., Gores, G. J. & Feldstein, A. E. The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicity. Hepatology 47, 1495\u20131503 (2008).","journal-title":"Hepatology"},{"key":"55939_CR65","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1053\/j.gastro.2015.04.009","volume":"149","author":"A Bettaieb","year":"2015","unstructured":"Bettaieb, A. et al. Hepatocyte nicotinamide adenine dinucleotide phosphate reduced oxidase 4 regulates stress signaling, fibrosis, and insulin sensitivity during development of steatohepatitis in mice. Gastroenterology 149, 468\u2013480.e410 (2015).","journal-title":"Gastroenterology"},{"key":"55939_CR66","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1172\/JCI88881","volume":"127","author":"Y Koyama","year":"2017","unstructured":"Koyama, Y. & Brenner, D. A. Liver inflammation and fibrosis. J. Clin. Invest 127, 55\u201364 (2017).","journal-title":"J. Clin. Invest"},{"key":"55939_CR67","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1172\/JCI18212","volume":"112","author":"R Bataller","year":"2003","unstructured":"Bataller, R. et al. NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. J. Clin. Invest 112, 1383\u20131394 (2003).","journal-title":"J. Clin. Invest"},{"key":"55939_CR68","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1002\/hep.24281","volume":"53","author":"YH Paik","year":"2011","unstructured":"Paik, Y. H. et al. The nicotinamide adenine dinucleotide phosphate oxidase (NOX) homologues NOX1 and NOX2\/gp91(phox) mediate hepatic fibrosis in mice. Hepatology 53, 1730\u20131741 (2011).","journal-title":"Hepatology"},{"key":"55939_CR69","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cell.2020.08.009","volume":"183","author":"Q Zhao","year":"2020","unstructured":"Zhao, Q. et al. Targeting mitochondria-located circRNA SCAR alleviates nash via reducing mros output. Cell 183, 76\u201393.e22 (2020).","journal-title":"Cell"},{"key":"55939_CR70","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1007\/s00125-016-4084-3","volume":"59","author":"TL Merry","year":"2016","unstructured":"Merry, T. L. et al. Hepatocyte glutathione peroxidase-1 deficiency improves hepatic glucose metabolism and decreases steatohepatitis in mice. Diabetologia 59, 2632\u20132644 (2016).","journal-title":"Diabetologia"},{"key":"55939_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101315","volume":"28","author":"MH Kim","year":"2020","unstructured":"Kim, M. H. et al. Peroxiredoxin 5 ameliorates obesity-induced non-alcoholic fatty liver disease through the regulation of oxidative stress and AMP-activated protein kinase signaling. Redox Biol. 28, 101315 (2020).","journal-title":"Redox Biol."},{"key":"55939_CR72","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1089\/ars.2012.4946","volume":"19","author":"A Nabeshima","year":"2013","unstructured":"Nabeshima, A. et al. Peroxiredoxin 4 protects against nonalcoholic steatohepatitis and type 2 diabetes in a nongenetic mouse model. Antioxid. Redox Signal 19, 1983\u20131998 (2013).","journal-title":"Antioxid. Redox Signal"},{"key":"55939_CR73","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1089\/ars.2018.7544","volume":"31","author":"DH Lee","year":"2019","unstructured":"Lee, D. H. et al. Peroxiredoxin 6 confers protection against nonalcoholic fatty liver disease through maintaining mitochondrial function. Antioxid. Redox Signal 31, 387\u2013402 (2019).","journal-title":"Antioxid. Redox Signal"},{"key":"55939_CR74","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nrd3403","volume":"10","author":"GR Drummond","year":"2011","unstructured":"Drummond, G. R., Selemidis, S., Griendling, K. K. & Sobey, C. G. Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat. Rev. Drug Discov. 10, 453\u2013471 (2011).","journal-title":"Nat. Rev. Drug Discov."},{"key":"55939_CR75","doi-asserted-by":"publisher","first-page":"902","DOI":"10.3389\/fphys.2017.00902","volume":"8","author":"G Carta","year":"2017","unstructured":"Carta, G., Murru, E., Banni, S. & Manca, C. Palmitic acid: physiological role, metabolism and nutritional implications. Front Physiol. 8, 902 (2017).","journal-title":"Front Physiol."},{"key":"55939_CR76","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1053\/j.gastro.2015.12.037","volume":"150","author":"P Hirsova","year":"2016","unstructured":"Hirsova, P. et al. Lipid-Induced signaling causes release of inflammatory extracellular vesicles from hepatocytes. Gastroenterology 150, 956\u2013967 (2016).","journal-title":"Gastroenterology"},{"key":"55939_CR77","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.tem.2017.11.009","volume":"29","author":"X Palomer","year":"2018","unstructured":"Palomer, X., Pizarro-Delgado, J., Barroso, E. & Vazquez-Carrera, M. Palmitic and oleic acid: the yin and yang of fatty acids in type 2 diabetes mellitus. Trends Endocrinol. Metab. 29, 178\u2013190 (2018).","journal-title":"Trends Endocrinol. Metab."},{"key":"55939_CR78","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1194\/jlr.M800042-JLR200","volume":"49","author":"ME Rinella","year":"2008","unstructured":"Rinella, M. E. et al. Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet. J. Lipid Res 49, 1068\u20131076 (2008).","journal-title":"J. Lipid Res"},{"key":"55939_CR79","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.cmet.2012.05.012","volume":"16","author":"K Imajo","year":"2012","unstructured":"Imajo, K. et al. Hyperresponsivity to low-dose endotoxin during progression to nonalcoholic steatohepatitis is regulated by leptin-mediated signaling. Cell Metab. 16, 44\u201354 (2012).","journal-title":"Cell Metab."},{"key":"55939_CR80","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/path.5548","volume":"253","author":"J Ryu","year":"2021","unstructured":"Ryu, J. et al. Differential TM4SF5-mediated SIRT1 modulation and metabolic signaling in nonalcoholic steatohepatitis progression. J. Pathol. 253, 55\u201367 (2021).","journal-title":"J. Pathol."},{"key":"55939_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18324-9","volume":"11","author":"D Talwar","year":"2020","unstructured":"Talwar, D., Messens, J. & Dick, T. P. A role for annexin A2 in scaffolding the peroxiredoxin 2-STAT3 redox relay complex. Nat. Commun. 11, 4512 (2020).","journal-title":"Nat. Commun."},{"key":"55939_CR82","doi-asserted-by":"publisher","first-page":"928","DOI":"10.2337\/dc21-1758","volume":"45","author":"S Gancheva","year":"2022","unstructured":"Gancheva, S. et al. Impaired Hepatic Mitochondrial Capacity in Nonalcoholic Steatohepatitis Associated With Type 2 Diabetes. Diabetes Care 45, 928\u2013937 (2022).","journal-title":"Diabetes Care"},{"key":"55939_CR83","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.cmet.2011.06.015","volume":"14","author":"X Xie","year":"2011","unstructured":"Xie, X. et al. C2 domain-containing phosphoprotein CDP138 regulates GLUT4 insertion into the plasma membrane. Cell Metab. 14, 378\u2013389 (2011).","journal-title":"Cell Metab."},{"key":"55939_CR84","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nchembio.935","volume":"8","author":"CX Liu","year":"2012","unstructured":"Liu, C. X. et al. Adenanthin targets peroxiredoxin I and II to induce differentiation of leukemic cells. Nat. Chem. Biol. 8, 486\u2013493 (2012).","journal-title":"Nat. Chem. Biol."},{"key":"55939_CR85","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41392-022-01231-4","volume":"8","author":"H Xu","year":"2023","unstructured":"Xu, H. et al. Celastrol suppresses colorectal cancer via covalent targeting peroxiredoxin 1. Signal Transduct. Target Ther. 8, 51 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"55939_CR86","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.cmet.2018.12.018","volume":"29","author":"X Xie","year":"2019","unstructured":"Xie, X. et al. Activation of anxiogenic circuits instigates resistance to diet-induced obesity via increased energy expenditure. Cell Metab. 29, 917\u2013931.e914 (2019).","journal-title":"Cell Metab."},{"key":"55939_CR87","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.cmet.2013.03.005","volume":"17","author":"V Mansuy-Aubert","year":"2013","unstructured":"Mansuy-Aubert, V. et al. Imbalance between neutrophil elastase and its inhibitor alpha1-antitrypsin in obesity alters insulin sensitivity, inflammation, and energy expenditure. Cell Metab. 17, 534\u2013548 (2013).","journal-title":"Cell Metab."},{"key":"55939_CR88","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1136\/gut.2008.149880","volume":"58","author":"B Lavina","year":"2009","unstructured":"Lavina, B. et al. Superoxide dismutase gene transfer reduces portal pressure in CCl4 cirrhotic rats with portal hypertension. Gut 58, 118\u2013125 (2009).","journal-title":"Gut"},{"key":"55939_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.101051","volume":"41","author":"LR Edmunds","year":"2020","unstructured":"Edmunds, L. R. et al. Liver-specific Prkn knockout mice are more susceptible to diet-induced hepatic steatosis and insulin resistance. Mol. Metab. 41, 101051 (2020).","journal-title":"Mol. Metab."},{"key":"55939_CR90","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1016\/j.molp.2020.09.013","volume":"13","author":"T Zhu","year":"2020","unstructured":"Zhu, T. et al. Normal structure and function of endothecium chloroplasts maintained by zmms33-mediated lipid biosynthesis in tapetal cells are critical for anther development in maize. Mol. Plant 13, 1624\u20131643 (2020).","journal-title":"Mol. Plant"},{"key":"55939_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.120155","volume":"255","author":"G Yang","year":"2020","unstructured":"Yang, G. et al. A multifunctional anti-inflammatory drug that can specifically target activated macrophages, massively deplete intracellular H(2)O(2), and produce large amounts CO for a highly efficient treatment of osteoarthritis. Biomaterials 255, 120155 (2020).","journal-title":"Biomaterials"},{"key":"55939_CR92","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1021\/acs.analchem.9b04860","volume":"92","author":"X Luo","year":"2020","unstructured":"Luo, X. et al. Detection of selenocysteine with a ratiometric near-infrared fluorescent probe in cells and in mice thyroid diseases model. Anal. Chem. 92, 1589\u20131597 (2020).","journal-title":"Anal. Chem."},{"key":"55939_CR93","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","volume":"569","author":"W Wang","year":"2019","unstructured":"Wang, W. et al. CD8(+) T cells regulate tumour ferroptosis during cancer immunotherapy. Nature 569, 270\u2013274 (2019).","journal-title":"Nature"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-55939-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-55939-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-55939-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T14:02:30Z","timestamp":1736604150000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-55939-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,11]]},"references-count":93,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["55939"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-55939-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,11]]},"assertion":[{"value":"21 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"598"}}